Table 1.
Sequencing type |
No. of patients |
No. of sequenced isolates |
Time span of isolate evolution (years) |
No. of studied lineages or clone types |
Identification of positively selected genes |
Reference |
---|---|---|---|---|---|---|
Whole-genome |
1 |
2 |
7.5 |
1 |
No |
[6] |
Gene-targeted |
29 |
58 |
5–20 |
nd |
No |
|
Whole-genome |
1 |
45 |
20 |
1 (PA14) |
No |
[7] |
1 |
63 |
23 |
1 (C) |
No |
||
Whole-genome |
6* |
12* |
35 max.* |
1 (DK2)* |
No |
[13]* |
Whole-genome |
21* |
55* |
36* |
1 (DK2)* |
Yes |
[14]* |
Whole-genome |
1 |
18 |
32 |
1 (DK1) |
No |
[9] |
Whole-genome |
1 |
13 |
6 |
1 |
Yes |
[8] |
1 |
14 |
20 |
1 |
|||
Whole-genome |
34 |
474 |
1–8 |
53 (36 for PE) |
Yes |
[16] |
Whole-genome |
4 |
26 |
17–19 |
6 |
Yes |
[18] |
Whole-genome |
1 |
2 |
6.9 |
1 (OC4A) |
No |
[10] |
Whole-genome |
1 |
2 |
3 |
1 |
No |
[12] |
Whole-genome |
32 (12 for PE) |
262 |
<15–35 |
12 |
Yes |
[17] |
Whole-genome |
13 (6 for PE) |
63 |
3–4 |
1 (AUST-02) |
Yes |
[15] |
Whole-genome |
1 |
40 |
8 |
1 |
Yes |
[11] |
Reanalysis of whole- genome sequencing |
68 |
534 |
nd |
44 |
Yes |
[81] |
nd, Not determined in the study; PE, parallel evolution.
*Isolates sequenced by Yang et al. were also used in the study by Marvig et al., making the results of these two studies interconnected [13, 14].